How Oxandrolone Affects HDL Cholesterol

Oxandrolone (Anavar) suppresses HDL via the same 17-alpha-alkylated hepatic lipase mechanism as stanozolol, but with moderate rather than severe effect. Despite its reputation as a 'mild' oral, oxandrolone is not lipid-neutral and produces clinically significant HDL reduction at bodybuilding doses.

The Mechanism

Oxandrolone suppresses HDL through the same mechanistic pathway as other 17-alpha-alkylated oral steroids, though with less potency per milligram:

  1. Hepatic lipase (HTGL) upregulation via first-pass metabolism: As a 17-AA oral, oxandrolone survives first-pass liver metabolism and delivers an androgenic signal to hepatocytes that upregulates HTGL, accelerating HDL catabolism.
  2. ApoA-I reduction: Like other orals, oxandrolone reduces ApoA-I production, impairing de novo HDL synthesis.
  3. No aromatisation: Oxandrolone does not aromatise to estradiol, removing the estrogenic HDL-protective counterbalance. However, the overall androgenic potency of oxandrolone is more moderate than stanozolol, producing a less extreme HTGL surge.
  4. Relative mitigation vs. other orals: Oxandrolone's milder androgenic potency results in less HTGL stimulation than stanozolol at equivalent milligram doses. This is why it is often described as "milder," but milder is not the same as neutral.

Expected Changes

At 10-20 mg/day (clinical and lower bodybuilding doses):

  • Moderate HDL suppression, typically 20-40% from baseline
  • A pre-cycle HDL of 50 mg/dL might fall to 30-40 mg/dL

At 24 mg/day (documented in clinical literature):

  • HDL has been documented falling to 24 mg/dL in controlled settings
  • Recovery to 49 mg/dL was observed within 3 months of cessation

At 40-80 mg/day (common bodybuilding doses):

  • Significant suppression expected (30-50%+)
  • The "mild" reputation often reflects low-dose comparisons; at high bodybuilding doses, oxandrolone's lipid impact becomes substantial

Recovery: Relatively faster than with stanozolol. HDL typically recovers to near-baseline within 2-3 months of stopping oxandrolone.

Monitoring Guidance

Baseline lipid panel before starting:

  • Know your pre-cycle HDL to accurately quantify the degree of suppression

On cycle:

  • Check lipids at week 4 of a typical 6-8 week cycle
  • If HDL has fallen below 25 mg/dL, consider dose reduction or cycle shortening

Post-cycle:

  • Recheck at 6-8 weeks after stopping. Recovery is generally faster than with stanozolol or trenbolone.

Management Strategies

During cycle:

  • Keep doses moderate (10-20 mg/day if possible); dose-response relationship is significant
  • Avoid stacking with other 17-alpha-alkylated orals; the hepatic load and lipid effects are additive
  • Cardiovascular exercise 30-45 minutes, 4-5 times per week
  • Omega-3 fatty acids 3-4 g EPA/DHA daily
  • Citrus bergamot 500-1000 mg/day as an adjunct

Contextual consideration:

  • Oxandrolone is often chosen for its relatively better lipid profile compared to stanozolol or anadrol, but the comparison is relative. It still suppresses HDL meaningfully, and users who believe "Anavar doesn't affect my cholesterol" are typically not measuring their lipids.

Clinical Significance

Oxandrolone is frequently described as a mild oral steroid, and relative to stanozolol or oxymetholone, that characterisation is accurate. However, mild is not the same as lipid-neutral. Clinical data document HDL falling to 24 mg/dL at relatively low doses. At the doses commonly used in bodybuilding (40-80 mg/day), suppression is meaningful and warrants monitoring. The faster recovery of HDL after oxandrolone cessation compared to heavier orals is a genuine advantage, but it does not eliminate the cardiovascular risk during active use.

Frequently Asked Questions

See how this interaction affects your blood work

Upload your blood tests and log your compounds to see personalised interaction data overlaid on your marker trends.

Quick Facts

Effect Direction

Suppresses

Severity

moderate

Dose-Dependent

Reversible